Todd Skrinar a leader in EY’s Life Sciences practice, Todd brings 22+ years experience applying technology for competitive advantage with both large and emerging organizations. Todd focuses on helping Life Sciences and Healthcare organizations realize the benefits highly visible business operations. Todd has a wide range of Life Sciences client experience including work with Amgen, Genentech, Merck, MedImmune, Actelion, Bio-Rad, Ortho Biotech and Solvay Pharmaceuticals. He has also worked extensively in the High Tech and Consumer Goods industries. Todd has a broad business process background including Marketing, Sales, Distribution and Logistics, and Business Analytics. His technical areas of expertise are ERP, CRM, Business Intelligence, web and collaboration.
Most recently at IBM Global Business Services, Todd was the Global Relationship Partner for Amgen and led the West Region of the Life Sciences practice. During his six years at IBM, Todd also played Strategy & Transformation Partner roles at Genentech, Novartis, Actelion and Bio-Rad.
Prior to IBM, Todd led the Health and Life Sciences consulting practice at Unisys where he led multiple analytics-driven transformation programs that spanned marketing, commercial operations, manufacturing and global supply chain management.
Before being recruited to start the Health and Life Sciences practice at Unisys, Todd played leadership roles at Collaborex and Riverton, both venture-funded technology start-ups focused on innovation opportunities in business-to-business e-commerce. Prior these roles, Todd was a Senior Manager at Price Waterhouse and PWC for seven years after beginning his career at Andersen Consulting.
Mr. Skrinar holds a Bachelor of Science degree in Business Management from Boston University and an MBA from Emory.
Todd has published on the topic of business analytics in life sciences. He is also a widely cited speaker on topics related to business analytics, supply chain visibility, brand protection and drug safety.
Todd has also been active in collaborations aimed at establishing industry standards for improved information sharing across the Health and Life Sciences ecosystem. These included a role as a Special Advisor to the Health and Life Sciences Business Action Group of EPCGlobal and Work Group Lead for an industry assessment and position statement to FDA regarding future adoption patterns for track and trace technology in the Health and Life Sciences industry.
Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security.
Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls.
© 2022 Corporate Compliance Insights
|cookielawinfo-checbox-analytics||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".|
|cookielawinfo-checbox-functional||11 months||The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".|
|cookielawinfo-checbox-others||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.|
|cookielawinfo-checkbox-necessary||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".|
|cookielawinfo-checkbox-performance||11 months||This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".|